Legalized Pot in California: No Gold Rush, No Cash Cow

There’s no way I will associate myself as a parent first, and as a public servant second, with something that is loosely drafted, that is looking to capitalize on the next California Gold Rush.
Lt. Gov Gavin Newsom

Our Blue Ribbon Commission on Marijuana Policy released our final report today (link here). The report is not an argument for or against legalization but a discussion of what the policy consideration should be if in fact California’s voters choose to legalize recreational marijuana. Gavin’s quote hits one of the key themes of the report, which is that protection of public health is more important than money generation (whether that money is corporate profits or state tax revenues). In America, public health only has a shot against big money if regulations are strong and the oversight process allows public input rather than being a cat’s paw of industry (As Oregon unfortunately has and Ohio might also adopt).

Relatedly, we advocate ongoing policy flexibility rather than a ballot initiative that sets everything in stone up front. The experience of other legalizing states shows that some anticipated problems don’t in fact occur whereas other things go unexpectedly pear-shaped. Because none of us can see the future with complete accuracy, any marijuana regulatory process will have to be dynamic and evolutionary in response.

Author: Keith Humphreys

Keith Humphreys is the Esther Ting Memorial Professor of Psychiatry at Stanford University and an Honorary Professor of Psychiatry at Kings College London. His research, teaching and writing have focused on addictive disorders, self-help organizations (e.g., breast cancer support groups, Alcoholics Anonymous), evaluation research methods, and public policy related to health care, mental illness, veterans, drugs, crime and correctional systems. Professor Humphreys' over 300 scholarly articles, monographs and books have been cited over thirteen thousand times by scientific colleagues. He is a regular contributor to Washington Post and has also written for the New York Times, Wall Street Journal, Washington Monthly, San Francisco Chronicle, The Guardian (UK), The Telegraph (UK), Times Higher Education (UK), Crossbow (UK) and other media outlets.